The widespread usage of early detection strategies based on prostate specific antigen (PSA) measurements have resulted in increased incidence of PC in US and Europe with increase of indolent disease and a decrease of metastatic disease [44]. This evidence concerns the gene KLK3 and pachyonychia congenita.